Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545281 - 545300 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EB01) gefitinib (adm: O) | IRESSA 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB01) gefitinib (adm: O) | IRESSA 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 30MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB03) afatinib (adm: O) | GILOTRIF 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 15MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
| USA | (L01EB07) dacomitinib (adm: O) | VIZIMPRO 30MG FCT 1X30 BTL US | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerInc. |
Pages
